Marc R Theoret - Center for Drug Evaluation and Research, U.S. Food and Drug Administration

基本信息

浏览量：16

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 205 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The BCR-SEQC Initiative

Rittika Mallik,Rebecca Kusko, Andrea C Baines, Reena Philip,Marc R Theoret, Eline T Luning Prak,Wenming Xiao

Nature immunology (2025)

引用0浏览0WOS引用

Supplementary Table S2 from FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation

Ashley C. Woods,Kelly J. Norsworthy, Moran Choe,Brenda J. Gehrke, Haiyan Chen,Jonathon Vallejo, Lili Pan,Xiling Jiang,Hongshan Li,Jeffrey Kraft,Jiang Liu,Rosane Charlab,Olanrewaju O. Okusanya,Brian Booth,Richard Pazdur,Marc R. Theoret,R. Angelo de Claro

crossref（2025）

引用0浏览0引用

FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation

Ashley C Woods,Kelly J Norsworthy, Moran Choe,Brenda J Gehrke, Haiyan Chen,Jonathon Vallejo, Lili Pan,Xiling Jiang,Hongshan Li,Jeffrey Kraft,Jiang Liu,Rosane Charlab,Olanrewaju O Okusanya,Brian Booth,Richard Pazdur,Marc R Theoret,R Angelo de Claro

Clinical cancer research an official journal of the American Association for Cancer Researchno. 1 (2025): 12-17

引用0浏览0WOS引用

Overall Survival and the Evolving Benefit-Risk Assessment for Poly (Adp-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer

Mirat Shah, Ting-Yu Chen,Gwynn Ison, Mallorie H Fiero,Hui Zhang,Xin Gao, Marc Neilson, Kirsten B Goldberg,Abhilasha Nair, Tiffany K Ricks,William F Pierce, Nicole Gormley,Marc R Theoret,Shenghui Tang,Richard Pazdur,Paul G Kluetz,Laleh Amiri-Kordestani

Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2402834-JCO2402834, (2025)

引用0浏览0WOS引用

Dosage Optimization of Pediatric Oncology Products: Our Patients Deserve Better

Kristin M Wessel, Nicole Drezner,Stacy S Shord, Mirat Shah,Marc R Theoret, Martha Donoghue

Clinical cancer research an official journal of the American Association for Cancer Research (2025)

引用0浏览0WOS引用

Supplementary Table S1 from FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation

crossref（2025）

引用0浏览0引用

FDA Approval Summary: Idecabtagene Vicleucel for the Treatment of Triple-Class Exposed, Relapsed or Refractory Multiple Myeloma

Poornima Sharma, Xue Lin, Zhenzhen Xu,Bindu Kanapuru,Marc R Theoret, Robert Sokolic, Lola A Fashoyin-Aje

Clinical cancer research an official journal of the American Association for Cancer Research (2025)

引用0浏览0WOS引用

Development of a Novel Methodology to Assess Response to Lymphoma Treatment in Real-World Data

Andrew J. Klink,Richard Scott Swain,Kristin M. Zimmerman Savill, Bindu Kalesan,Parisa Asgarisabet,Alexandrina Balanean, Harlen Hays,Jill Kaufman,Lindsay McAllister, Hsing-Ting Yu,Jalyna R. Laney,Nicholas C. Richardson,Catherine C. Lerro,Fatima Rizvi,Jonathon Vallejo, Kun Wang,Marc R. Theoret,Donna Rivera,Bruce A. Feinberg

JOURNAL OF CLINICAL ONCOLOGY（2024）

引用0浏览0引用

FDA Approval Summary: Teclistamab-A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple Myeloma

Andrea C Baines,Bindu Kanapuru, Jay Zhao,Lauren S L Price, Nan Zheng, Robyn Konicki,Michael L Manning,Brenda J Gehrke,Marc R Theoret,Nicole J Gormley

Clinical cancer research an official journal of the American Association for Cancer Researchno. 24 (2024): 5515-5520

引用0浏览0WOS引用

FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation

Gulsum E. Pamuk,Edwin C. Y. Chow,Alexei C. Ionan,Haiyan Chen,Shwu-Luan Lee,Vicky Hsu,Manuela Grimstein,Nan Zheng,Jielin Sun,Rosane Charlab,Brenda J. Gehrke,Jonathon Vallejo,Lori A. Ehrlich,R. Angelo de Claro,Marc R. Theoret

Clinical Cancer Research (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn